Phase 2 trial of Oxford Covid vaccine to begin today

​The observer-blind, randomised controlled study to determine the safety and immunogenicity of "Covishield" on healthy Indian adults will begin at Bharati Vidyapeeth Medical College and Hospital in Pune. Via Times of India https://ift.tt/2hJjhqE